$NK News Article - NantKwest and ImmunityBio Prese
Post# of 30
(Total Views: 259)
Posted On: 12/16/2019 8:00:42 AM
$NK News Article - NantKwest and ImmunityBio Present Results of Landmark Trial of First-in-Human Natural Killer Cell Combination Immunotherapy With Durable, Complete Response Data and 78% Disease Control in Refractory Triple Negative Breast Cancer at SABCS https://marketwirenews.com/news-releases/nant...88585.html
(0)
(0)NantKwest Inc. (NK) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼